P
PolyPhotonix
Polyphotonix designs, develops, and manufactures non-invasive photonic-based medical devices
About PolyPhotonix
PolyPhotonix is a pioneering biophotonic research and development company that specializes in designing, developing, and manufacturing non-invasive photonic-based medical devices. Operating primarily in the healthcare sector, PolyPhotonix serves patients suffering from Diabetic Retinopathy, a condition that affects the eyes of diabetic individuals. The company's flagship product, the Noctura 400 Sleep Mask, offers a home-based, monitored treatment that is significantly less invasive and more cost-effective compared to traditional methods like laser photocoagulation and intravitreal injections. The business model revolves around the sale of these innovative medical devices, which are designed to improve patient outcomes and reduce healthcare costs. PolyPhotonix generates revenue through direct sales to consumers and partnerships with healthcare providers. The company has received multiple awards for its innovative contributions to healthcare, including the NHS innovation award and the Market Gravity Innovation Award.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2009
- Headquarters
- Stockton-on-Tees, United Kingdom
- Employees
- 13
- Open positions
- None listed
- Dealroom signal
- 55.5/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Hard Tech, uk is8 life sciences
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBT✓Debt | Feb 2024 | $132K | — | NPIF - FW Capital | ↗ |
| LATE VC✓Equity / VC | Feb 2022 | $10M | $40M | Prevail InfoWorks | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for PolyPhotonix is 2.6K monthly website visits, up 622.2% over the last three months. PolyPhotonix's team grew 0% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
SBRI Healthcare
Series B and later2 investors entered at this stage
Prevail InfoWorks- NCNPIF - FW Capital
Other known investors1 additional known investor
Centre for Process Innovation
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about PolyPhotonix on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See PolyPhotonix’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.